TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 19 | -87.3% | 0.00% | – |
| Q2 2023 | $0 | – | 150 | +581.8% | 0.00% | – |
| Q1 2023 | $0 | – | 22 | -8.3% | 0.00% | – |
| Q4 2022 | $0 | – | 24 | +26.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 19 | -98.1% | 0.00% | – |
| Q2 2022 | $4,000 | -75.0% | 1,019 | -57.7% | 0.00% | – |
| Q1 2022 | $16,000 | -69.8% | 2,411 | -47.8% | 0.00% | – |
| Q4 2021 | $53,000 | +39.5% | 4,615 | +128.8% | 0.00% | – |
| Q3 2021 | $38,000 | +18.8% | 2,017 | +31.7% | 0.00% | – |
| Q2 2021 | $32,000 | +77.8% | 1,532 | +75.1% | 0.00% | – |
| Q1 2021 | $18,000 | +50.0% | 875 | +86.6% | 0.00% | – |
| Q4 2020 | $12,000 | – | 469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |